BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 25449991)

  • 21. Effects of sildenafil on maximum walking time in patients with arterial claudication: The ARTERIOFIL study.
    Omarjee L; Le Pabic E; Custaud MA; Fontaine C; Locher C; Renault A; Jaquinandi V; Azzola V; Barbeau-Terrier C; Laporte I; Ripoche M; Onillon Y; Chretien JM; Daniel V; Chao de la Barca JM; Homedan C; Reynier P; Abraham P; Mahé G
    Vascul Pharmacol; 2019; 118-119():106563. PubMed ID: 31152977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Education and home based training for intermittent claudication: functional effects and quality of life.
    Prévost A; Lafitte M; Pucheu Y; Couffinhal T;
    Eur J Prev Cardiol; 2015 Mar; 22(3):373-9. PubMed ID: 24177266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Wearable Activity Monitors in Home Based Exercise Therapy for Patients with Intermittent Claudication: A Systematic Review.
    Chan C; Sounderajah V; Normahani P; Acharya A; Markar SR; Darzi A; Bicknell C; Riga C
    Eur J Vasc Endovasc Surg; 2021 Apr; 61(4):676-687. PubMed ID: 33451865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pain-free treadmill exercise for patients with intermittent claudication: Are there gender differences?
    Dipnarine K; Barak S; Martinez CA; Carmeli E; Stopka CB
    Vascular; 2016 Jun; 24(3):304-14. PubMed ID: 26209234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Home-based exercise for elderly patients with intermittent claudication limited by osteoarticular disorders - feasibility and effectiveness of a low-intensity programme.
    Lamberti N; Straudi S; Lissia E; Cavazzini L; Buja S; Manfredini R; Basaglia N; Manfredini F
    Vasa; 2018 Apr; 47(3):227-234. PubMed ID: 29463192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intensive walking exercise for lower extremity peripheral arterial disease: A systematic review and meta-analysis.
    Lyu X; Li S; Peng S; Cai H; Liu G; Ran X
    J Diabetes; 2016 May; 8(3):363-77. PubMed ID: 25940390
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of peripheral arterial disease and supervised walking on heart rate variability.
    Leicht AS; Crowther RG; Golledge J
    J Vasc Surg; 2011 Nov; 54(5):1352-9. PubMed ID: 21784603
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development and evaluation of the Walking Estimated-Limitation Calculated by History questionnaire in patients with claudication.
    Ouedraogo N; Chanut M; Aubourg M; Le Hello C; Hidden V; Audat G; Harbonnier M; Abraham P
    J Vasc Surg; 2013 Oct; 58(4):981-8. PubMed ID: 23663870
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Change of walking distance in intermittent claudication: impact on inflammation, oxidative stress and mononuclear cells: a pilot study.
    Dopheide JF; Scheer M; Doppler C; Obst V; Stein P; Vosseler M; Abegunewardene N; Gori T; Münzel T; Daiber A; Radsak MP; Espinola-Klein C
    Clin Res Cardiol; 2015 Sep; 104(9):751-63. PubMed ID: 25772524
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The walking impairment questionnaire: an effective tool to assess the effect of treatment in patients with intermittent claudication.
    Nicolaï SP; Kruidenier LM; Rouwet EV; Graffius K; Prins MH; Teijink JA
    J Vasc Surg; 2009 Jul; 50(1):89-94. PubMed ID: 19563956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy of ankle-foot orthoses on walking ability in peripheral artery disease.
    Mays RJ; Mays AA; Mizner RL
    Vasc Med; 2019 Aug; 24(4):324-331. PubMed ID: 30924412
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Minimally Important Difference of the Absolute and Functional Claudication Distance in Patients with Intermittent Claudication.
    van den Houten MM; Gommans LN; van der Wees PJ; Teijink JA
    Eur J Vasc Endovasc Surg; 2016 Mar; 51(3):404-9. PubMed ID: 26715076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clot strength is negatively associated with ambulatory function in patients with peripheral artery disease and intermittent claudication.
    Mauer K; Gardner AW; Dasari TW; Stoner JA; Blevins SM; Montgomery PS; Saucedo JF; Exaire JE
    Angiology; 2015 Apr; 66(4):354-9. PubMed ID: 24778425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The development and pilot randomised controlled trial of a group education programme for promoting walking in people with intermittent claudication.
    Tew GA; Humphreys L; Crank H; Hewitt C; Nawaz S; Al-Jundi W; Trender H; Michaels J; Gorely T
    Vasc Med; 2015 Aug; 20(4):348-57. PubMed ID: 25858012
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Effect of Structured Patient Education on Physical Activity in Patients with Peripheral Arterial Disease and Intermittent Claudication: A Systematic Review.
    Abaraogu UO; Dall PM; Seenan CA
    Eur J Vasc Endovasc Surg; 2017 Jul; 54(1):58-68. PubMed ID: 28528678
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial.
    Ahimastos AA; Walker PJ; Askew C; Leicht A; Pappas E; Blombery P; Reid CM; Golledge J; Kingwell BA
    JAMA; 2013 Feb; 309(5):453-60. PubMed ID: 23385271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effect of pain-free treadmill training on fibrinogen, haematocrit, and lipid profile in patients with claudication.
    Mika P; Wilk B; Mika A; Marchewka A; Nizankowski R
    Eur J Cardiovasc Prev Rehabil; 2011 Oct; 18(5):754-60. PubMed ID: 21450630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perceived Versus Objective Change in Walking Ability in Peripheral Artery Disease: Results from 3 Randomized Clinical Trials of Exercise Therapy.
    McDermott MM; Tian L; Criqui MH; Ferrucci L; Greenland P; Guralnik JM; Kibbe MR; Li L; Sufit R; Zhao L; Polonsky TS
    J Am Heart Assoc; 2021 Jun; 10(12):e017609. PubMed ID: 34075780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A systematic review of lower extremity electrical stimulation for treatment of walking impairment in peripheral artery disease.
    Jéhannin P; Craughwell M; Omarjee L; Donnelly A; Jaquinandi V; Mahé G; Le Faucheur A
    Vasc Med; 2020 Aug; 25(4):354-363. PubMed ID: 32303155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Autologous bone marrow cell therapy for patients with peripheral arterial disease: a meta-analysis of randomized controlled trials.
    Wen Y; Meng L; Gao Q
    Expert Opin Biol Ther; 2011 Dec; 11(12):1581-9. PubMed ID: 21973046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.